Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
We compare which structure offers superior tax efficiency between dividend ETFs and taxable funds, focusing on after-tax returns and fees.
28,247 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Three very different tech leaders share surprising similarities that matter to investors. This guide uncovers common ...
A veteran hedge-fund manager behind an early SpaceX investment argues the AI-driven bottleneck trade is fading, trigg...
Meta Platforms unveils a multi-year AI infrastructure push totaling up to $145 billion, reshaping supplier valuations...
The United States plans to deploy Merops, an AI-powered anti-drone system, to the Middle East to counter Iranian Shah...
Market turmoil from Middle East conflict has pushed oil higher, yet economists say the energy crisis isn’t recessiona...
The Supreme Court looks poised to restrict late mail ballots, a move that could impact voter turnout and state electi...
Tesla is signaling a profitability-focused future with autonomy and robotics, while BYD drives volume with affordable...
Artificial intelligence stocks have powered market gains and drawn fierce interest. This guide breaks down what the d...
As BioHarvest gears up for its Q1 2026 earnings, investors seek clarity on revenue momentum, margins, and the path to...
A global push to deploy AI-ready data centers is boosting capital spending toward a roughly $1 trillion wave that cou...
Greg Abel, Warren Buffett's successor, signals a bold shift by entering Macy's. This piece breaks down the strategy, ...